Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v7-EN
Language French English
Date Updated 2018-07-30 2018-03-13
Drug Identification Number 02389622 02389622
Brand name TEVA-TOBRAMYCIN TEVA-TOBRAMYCIN
Common or Proper name TOBRAMYCIN TOBRAMYCIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TOBRAMYCIN TOBRAMYCIN
Strength(s) 60MG 60MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION
Packaging size 5 5
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-29 2017-12-29
Estimated end date 2018-07-06 2018-07-06
Actual end date 2018-07-12
Shortage status Resolved Actual shortage
Company comments
Health Canada comments